News
Marlborough: Boston Scientific Corporation has announced that the company has received approval from the U.S. Food and Drug ...
10d
GlobalData on MSNFDA approves label updates for BMS’ CAR T cell therapiesBristol Myers Squibb (BMS) has announced that the US Food and Drug Administration (FDA) has given approval to label updates ...
The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.
The Food and Drug Administration (FDA) has approved an updated label for Amyvid (florbetapir F 18 injection) to support Alzheimer disease diagnosis in patients.
Discover why synthetic food dyes are being phased out in the US, how major brands are responding, and what challenges the ...
Label updates have been approved by the FDA for the CAR T-cell therapies Breyanzi and Abecma in large B cell lymphoma and ...
KalVista Pharmaceuticals Inc, a clinical-stage pharmaceutical company listed on the S&P 500, has achieved a significant ...
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...
Opinion: Orrick's Irena Royzman and Dana Sublett write that judges have done a good job in multiple decisions that protect ...
Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...
The Breyanzi REMS program and the Abecma REMS program were established due to the risk of cytokine release syndrome and neurologic toxicities.
The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings about the risk of weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results